GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eli Lilly and Co (XPAR:LLY) » Definitions » Cash Flow for Dividends

Eli Lilly and Co (XPAR:LLY) Cash Flow for Dividends : €-3,901 Mil (TTM As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Eli Lilly and Co Cash Flow for Dividends?

Eli Lilly and Co's cash flow for dividends for the three months ended in Mar. 2024 was €-1,076 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2024 was €-3,901 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Eli Lilly and Co's quarterly payment of dividends declined from Sep. 2023 (€-952 Mil) to Dec. 2023 (€-934 Mil) but then increased from Dec. 2023 (€-934 Mil) to Mar. 2024 (€-1,076 Mil).

Eli Lilly and Co's annual payment of dividends increased from Dec. 2021 (€-2,732 Mil) to Dec. 2022 (€-3,338 Mil) and increased from Dec. 2022 (€-3,338 Mil) to Dec. 2023 (€-3,732 Mil).

Eli Lilly and Co Cash Flow for Dividends Historical Data

The historical data trend for Eli Lilly and Co's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eli Lilly and Co Cash Flow for Dividends Chart

Eli Lilly and Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2,168.82 -2,208.80 -2,731.82 -3,337.80 -3,731.55

Eli Lilly and Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -950.07 -939.43 -952.18 -933.60 -1,075.66

Eli Lilly and Co Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-3,901 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eli Lilly and Co Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Eli Lilly and Co's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Eli Lilly and Co (XPAR:LLY) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eli Lilly and Co (XPAR:LLY) » Definitions » Cash Flow for Dividends
Comparable Companies
JNJ MRK ABBV AMGN PFE BMY GILD BIIB OGN AMRN LSE:AZN XSWX:NOVN XSWX:ROG XPAR:SAN LSE:GSK TSE:4568 TSE:4519 SHSE:600276 XTER:BAYN TSE:4578
Traded in Other Exchanges
LLY:USA LLY:Mexico 1LLY:Italy LLY:Germany LLY:Switzerland LLY:Canada LILY34:Brazil LLYC:Austria LLY:Argentina
Address
Lilly Corporate Center, Indianapolis, IN, USA, 46285
Website
https://www.lilly.com
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.